Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/603079 stock hub

SHA/603079 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/603079is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/603079

In the news

Latest news · SHA/603079

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E54.4

P25 23.5P50 41.3P75 83.2

ROE4.2

P25 -0.9P50 4.1P75 8.8

ROIC5.3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/603079 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

CNY

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,035
Employees Change	3%
Employees Change Percent	0.29
Enterprise value	CNY 2.5B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002W43
Last refreshed	2026-05-10
Market cap	CNY 3B
Price	CNY 15.95
Price currency	CNY
Rev Per Employee	802,442.08x
Sector	Healthcare
Sic	2834
Symbol	sha/603079
Website	https://www.sd-pharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.8%
EV Earnings	47.09x
EV/EBIT	33.75x
EV/EBITDA	16.52x
EV/FCF	180.52x
EV/Sales	3.04x
FCF yield	0.47%
P/B ratio	1.83x
P/E ratio	54.4x
P/S ratio	3.59x
PE Ratio10 Y	54.91x
PE Ratio5 Y	57.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.01%
EBITDA Margin	18.3%
FCF margin	1.68%
Gross margin	25.81%
Gross Profit	CNY 214.4M
Gross Profit Growth	8.51%
Gross Profit Growth Q	-1.45%
Gross Profit Growth3 Y	32.89%
Gross Profit Growth5 Y	-11.85%
Net Income	CNY 53.6M
Net Income Growth	13.31%
Net Income Growth Q	70.1%
Net Income Growth Years	2%
Net Income Growth3 Y	55.81%
Net Income Growth5 Y	-19.48%
Pretax Margin	8.55%
Profit Margin	6.46%
Profit Per Employee	CNY 51,808
Profitable Years	2
ROA	2.34
Roa5y	0.71
ROCE	3.77
ROE	4.16
Roe5y	2.24
ROIC	5.29
Roic5y	1.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-9.17%
Cagr3y	8.62%
Cagr5y	-1.97%
Div CAGR3	-44.45%
Div CAGR5	-6.88%
EPS Growth	3.57
EPS Growth Q	73.57
EPS Growth Years	2
EPS Growth3 Y	53.6
EPS Growth5 Y	-20.7
FCF Growth5 Y	-44.76%
OCF Growth	16.53%
OCF Growth3 Y	309.87%
OCF Growth5 Y	-15.17%
Revenue Growth	-1.81x
Revenue Growth Q	-13.42x
Revenue Growth Years	2x
Revenue Growth3 Y	4.77x
Revenue Growth5 Y	-0.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.42
Assets	CNY 2.2B
Cash	CNY 823M
Current Assets	CNY 986.4M
Current Liabilities	CNY 210.5M
Debt	CNY 330.7M
Debt EBITDA	CNY 2.16
Debt Equity	CNY 0.2
Debt FCF	CNY 23.64
Equity	CNY 1.6B
Liabilities	CNY 562M
Long Term Assets	CNY 1.2B
Long Term Liabilities	CNY 351.5M
Net Cash	CNY 492.3M
Net Cash By Market Cap	CNY 16.49
Net Cash Growth	825.48%
Net Debt EBITDA	CNY -3.24
Net Debt Equity	CNY -0.3
Net Debt FCF	CNY -35.19
Tangible Book Value	CNY 1.4B
Tangible Book Value Per Share	CNY 7.26
WACC	5.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.69
Net Working Capital	CNY -47.1M
Quick ratio	4.58
Working Capital	CNY 775.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-9.4%
Dividend per share	CNY 0
Last Dividend	CNY 0.06
Payout Ratio	14.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-9.17%
200-day SMA	18.16
3Y total return	28.14%
50-day SMA	17.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-9.49%
All Time High	43.91
All Time High Change	-63.67%
All Time High Date	2020-02-24
All Time Low	7.01
All Time Low Change	127.53%
All Time Low Date	2024-02-08
ATR	0.66
Beta	0.4
Beta1y	0.28
Beta2y	0.19
Ch YTD	-9.99
High	16.09
High52	22
High52 Date	2026-01-23
High52ch	-27.5%
Low	15.8
Low52	15.17
Low52 Date	2026-03-23
Low52ch	5.14%
Ma50ch	-7.26%
Price vs 200-day SMA	-12.18%
RSI	41.03
RSI Monthly	49.62
RSI Weekly	40.28
Sharpe ratio	-0x
Sortino ratio	0.15
Total Return	-9.4%
Tr YTD	-9.99
Tr1m	-6.51%
Tr1w	-1.85%
Tr3m	-19.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 74.8M
Operating Income Growth	0.18
Operating Income Growth Q	-20.11
Operating Income Growth5 Y	-18.94
Operating margin	9.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	93,938,946%
Net Borrowing	48,500,000
Shares Insiders	2.74%
Shares Institutions	3.87%
Shares Out	187,157,124
Shares Qo Q	6.35%
Shares Yo Y	9.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 14M
Average Volume	3,949,382.4x
Bv Per Share	8.49
CAPEX	CNY -142.8M
Ch1m	-6.51
Ch1w	-1.85
Ch1y	-9.17
Ch3m	-19.81
Ch3y	26.79
Ch5y	-13.17
Ch6m	-23.61
Change	0.31%
Change From Open	0.25
Close	15.9
Days Gap	0.06
Depreciation Amortization	77,130,609
Dollar Volume	58,290,806.2
Earnings Date	2026-04-27
EBIT	CNY 74.8M
EBITDA	CNY 151.9M
EPS	CNY 0.29
F Score	6
FCF	CNY 14M
FCF EV Yield	0.55x
FCF Per Share	CNY 0.07
Financing CF	304,445,844
Fiscal Year End	December
Founded	1,999
Goodwill	10,909,393
Graham Number	7.48427
Graham Upside	-53.08
Income Tax	CNY 9.8M
Investing CF	-148,444,745
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2020-06-08
Last Split Type	Forward
Lynch Fair Value	CNY 1.47
Lynch Upside	-90.81
Ma150	18.18
Ma150ch	-12.28%
Ma20	16.55
Ma20ch	-3.63%
Net CF	308,154,882
Open	15.91
P FCF Ratio	213.4
P OCF Ratio	19.04
Position In Range	51.72
Ppne	919,712,870
Price Date	2026-05-08
Price EBITDA	CNY 19.65
Ptbv Ratio	2.19
Relative Volume	0.93x
Revenue	830,527,554x
Tax By Revenue	1.18x
Tax Rate	13.83%
Tr6m	-23.61%
Volume	3,654,596

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SHA/603079 pay a dividend?

Capital-return profile for this ticker.

Performance

SHA/603079 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/603079?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.9%

Share of float held by funds and institutions

Insider ownership

+2.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+9.4%

Negative means the company is buying back shares.

Technical

SHA/603079 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.0

Neutral momentum band

Price vs 200-day MA

-12.2%

50/200-day relationship not available

Beta (5Y)

0.40

Less volatile than the market

Sharpe ratio

-0.00

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/603079

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603079 stock rating?

sha/603079 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603079 analysis?

The full report lives at /stocks/sha/603079/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603079?

The latest report frames sha/603079 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603079 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.